MARIA CLARA
ALVAREZ VILLAMARIN
Catedrática de universidade
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (3)
2018
-
Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476
2017
1991
-
Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat
Neuroendocrinology, Vol. 53, Núm. 2, pp. 185-189